Wang X - Search Results

1

Investigation on the regulatory T cells signature and relevant Foxp3/STAT3 axis in esophageal cancer.

Yang L, Zhao Q, Wang X, Pilapong C, Li Y, Zou J, Jin J, Rong J. Yang L, et al. Among authors: wang x. Cancer Med. 2023 Feb;12(4):4993-5008. doi: 10.1002/cam4.5194. Epub 2022 Oct 13. Cancer Med. 2023. PMID: 36226375 Free PMC article.

2

High Expression of Indoleamine 2, 3-Dioxygenase in Adenosquamous Lung Carcinoma Correlates with Favorable Patient Outcome.

Ma W, Duan H, Zhang R, Wang X, Xu H, Zhou Q, Zhang L. Ma W, et al. Among authors: wang x. J Cancer. 2019 Jan 1;10(1):267-276. doi: 10.7150/jca.27507. eCollection 2019. J Cancer. 2019. PMID: 30662547 Free PMC article.

3

Study of TRAF3IP3 for prognosis and immune infiltration in hepatocellular carcinoma.

Wang X, Gao X, Liu A, Qin Y, Ni ZY, Zhang XL. Wang X, et al. PeerJ. 2024 Dec 12;12:e18538. doi: 10.7717/peerj.18538. eCollection 2024. PeerJ. 2024. PMID: 39677949 Free PMC article.

4

Effect of Lycopene on Oral Squamous Cell Carcinoma Cell Growth by Inhibiting IGF1 Pathway.

Tao A, Wang X, Li C. Tao A, et al. Among authors: wang x. Cancer Manag Res. 2021 Jan 26;13:723-732. doi: 10.2147/CMAR.S283927. eCollection 2021. Cancer Manag Res. 2021. PMID: 33531840 Free PMC article.

5

LPCAT3 is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis.

Ke P, Bao X, Liu C, Zhou B, Huo M, Chen Y, Wang X, Wu D, Ma X, Liu D, Chen S. Ke P, et al. Among authors: wang x. Transl Cancer Res. 2022 Oct;11(10):3491-3505. doi: 10.21037/tcr-22-985. Transl Cancer Res. 2022. PMID: 36388050 Free PMC article.

6

Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance.

Chen M, Wu X, Ma W, Zhou Q, Wang X, Zhang R, Wang J, Yang X. Chen M, et al. Among authors: wang x, wang j. Cancer Biomark. 2017 Dec 12;21(1):23-28. doi: 10.3233/CBM-170172. Cancer Biomark. 2017. PMID: 29036784

7

Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis.

Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C, Zhou Q, Chen X, Li Y, Lim Z, Wang X, Wang J, Yang X. Li Z, et al. Among authors: wang x, wang j. Cell Death Dis. 2017 Jun 22;8(6):e2888. doi: 10.1038/cddis.2017.245. Cell Death Dis. 2017. PMID: 28640252 Free PMC article.

8

Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2.

Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li Y, Gu L, Zhou Q, Zhu H, Li Y, Tan C, Yang X, Zhang Z. Wu X, et al. Among authors: wang x. Oncotarget. 2017 Jun 27;8(44):76015-76028. doi: 10.18632/oncotarget.18638. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100288 Free PMC article.

9

CSMD1 suppresses cancer progression by inhibiting proliferation, epithelial-mesenchymal transition, chemotherapy-resistance and inducing immunosuppression in esophageal squamous cell carcinoma.

Wang X, Chen X, Liu Y, Huang S, Ding J, Wang B, Dong P, Sun Z, Chen L. Wang X, et al. Among authors: wang b. Exp Cell Res. 2022 Aug 15;417(2):113220. doi: 10.1016/j.yexcr.2022.113220. Epub 2022 May 25. Exp Cell Res. 2022. PMID: 35623420

10

The application and mechanism of PD pathway blockade for cancer therapy.

Wang X, Huang S, Zhang Y, Zhu L, Wu X. Wang X, et al. Postgrad Med J. 2018 Jan;94(1107):53-60. doi: 10.1136/postgradmedj-2017-135187. Epub 2017 Sep 23. Postgrad Med J. 2018. PMID: 28942432 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211,813 results

Search Page

Filters